# A Trial to Reduce Hepatitis C Among Injection Drug Users - 1

> **NCT00218192** · PHASE3 · COMPLETED · sponsor: **Butler Hospital** · enrollment: 277 (actual)

## Conditions studied

- HCV Negative Status
- HCV Risk Behavior

## Interventions

- **BEHAVIORAL:** Behavior Therapy

## Key facts

- **NCT ID:** NCT00218192
- **Lead sponsor:** Butler Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-09
- **Primary completion:** 2006-11
- **Final completion:** 2006-11
- **Target enrollment:** 277 (ACTUAL)
- **Last updated:** 2015-05-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00218192

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00218192, "A Trial to Reduce Hepatitis C Among Injection Drug Users - 1". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00218192. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*